RSV prophylaxis guideline changes and outcomes in children with congenital heart disease

ConclusionsOur findings provide additional support for the new guideline recommendations to provide respiratory syncytial virus prophylaxis only for children ≤12 months old with congenital heart disease.

Source: Congenital Heart Disease - January 1, 2018 Category: Cardiology Authors: Adam S. Walpert, Ian D. Thomas, Merlin C. Lowe, Michael D. Seckeler Tags: ORIGINAL ARTICLE Source Type: research